Brain tumor patients get virus injection in new trial
Disease control
Not yet recruiting
This early-stage trial tests a modified herpes virus (C5252) injected directly into the brain tumor cavity in 36 adults with recurrent high-grade glioma who have no other treatment options. The goal is to see if the treatment is safe and tolerable, and to get an early look at whe…
Phase: PHASE1, PHASE2 • Sponsor: ImmVira Pharma Co. Ltd • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC